Drug Trial Radar · NCT03662022
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Last checked: Nov 19, 2026Latest source record: Mar 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
144,000
Actual
Start
Jan 2, 2019
Primary completion
Jan 17, 2023
Study completion Jan 17, 2023
Sponsor
- Lead sponsor
- Institute of Tropical Medicine, BelgiumAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Damien Foundation; Centre d'Infectiologie Charles Mérieux; Fondation Raoul Follereau; Leiden University Medical Center; L'Institut National de la Santé et de la Recherche Médicale; Genoscreen; Instituto Fernandes Figueira
- First posted
- Sep 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a cluster randomized trial on effectiveness of different modalities of Single Double Dose of Rifampicin Post-Exposure Prophylaxis (SDDR-PEP) for leprosy in the Comoros (Anjouan and Mohéli) and Madagascar. The study aims to identify which approach to the selection of contacts for post exposure prophylaxis is most effective to reduce incident leprosy, and to Interrupt ongoing transmission from asymptomatic persons in the process of developing multibacillary leprosy.
Conditions
- Leprosy
Interventions
RifampicinDrug
Rifampicin will be given in the same way to arms 2, 3 and 4 (weight dependent). Only the strategy of whom to offer PEP differs between the arms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare Effectiveness in Curbing Transmission of Leprosy of Three Different Approaches of Post Exposure ProphylaxisTime frame: 45 months
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Damien Foundation
Anjouan, Comoros
Damien Foundation
Mohéli, Comoros
Fondation Raoul Follereau
Miandrivazo, Menabe Region, Madagascar
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.